PMC:7228307 / 2983-3275 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T32","span":{"begin":24,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0050884"}],"text":"placing them in the top ten drugs globally.2 MAb development is expanding rapidly with over 100 mAbs approved for clinical use or in late‐stage clinical trials and over 600 in various stages of clinical development.1\nThe therapeutic actions of mAbs can take many forms—neutralization of the t"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10","span":{"begin":28,"end":33},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"placing them in the top ten drugs globally.2 MAb development is expanding rapidly with over 100 mAbs approved for clinical use or in late‐stage clinical trials and over 600 in various stages of clinical development.1\nThe therapeutic actions of mAbs can take many forms—neutralization of the t"}